These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 10461364

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quantitative structure-activity relationship study on some nonpeptidal cholecystokinin antagonists.
    Sinha J, Kurup A, Paleti A, Gupta SP.
    Bioorg Med Chem; 1999 Jun; 7(6):1127-30. PubMed ID: 10428383
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recent advances in the chemistry of cholecystokinin receptor ligands (agonists and antagonists).
    de Tullio P, Delarge J, Pirotte B.
    Curr Med Chem; 1999 Jun; 6(6):433-55. PubMed ID: 10213792
    [Abstract] [Full Text] [Related]

  • 11. Influence of gastrin on human astrocytic tumor cell proliferation.
    Camby I, Salmon I, Danguy A, Pasteels JL, Brotchi J, Martinez J, Kiss R.
    J Natl Cancer Inst; 1996 May 01; 88(9):594-600. PubMed ID: 8609660
    [Abstract] [Full Text] [Related]

  • 12. Role of N- and C-terminal substituents on the CCK-B agonist-antagonist pharmacological profile of Boc-Trp-Phg-Asp-Nal-NH2 derivatives.
    Weng JH, Blommaert AG, Moizo L, Bado A, Ducos B, Böhme A, Garbay C, Roques BP.
    Bioorg Med Chem; 1996 Apr 01; 4(4):563-73. PubMed ID: 8735845
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Minor modifications of a cholecystokinin-B/gastrin receptor non-peptide antagonist confer a broad spectrum of functional properties.
    Beinborn M, Quinn SM, Kopin AS.
    J Biol Chem; 1998 Jun 05; 273(23):14146-51. PubMed ID: 9603914
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.
    Schmassmann A, Garner A, Flogerzi B, Hasan MY, Sanner M, Varga L, Halter F.
    Gut; 1994 Feb 05; 35(2):270-4. PubMed ID: 8307482
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cytosolic Ca2+ evaluation in rabbit parietal cells: a novel method to screen gastrin receptor antagonists.
    Letari O, Mennuni L, Revel L, Colombo S, Makovec F.
    Eur J Pharmacol; 1996 Jun 13; 306(1-3):325-33. PubMed ID: 8813647
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.